Oruka licenses Halozyme Hypercon technology to develop psoriasis drug ORKA-001

Oruka Therapeutics, Inc.
Halozyme Therapeutics, Inc.

Oruka Therapeutics, Inc.

ORKA

0.00

Halozyme Therapeutics, Inc.

HALO

0.00
  • Oruka Therapeutics entered global exclusive collaboration, license agreement with Halozyme unit Halozyme Hypercon to use Hypercon technology with ORKA-001 for psoriasis, related inflammatory diseases.
  • Deal grants Oruka exclusive rights to use Hypercon with IL-23p19 in psoriatic disease, includes option to add one more target.
  • Oruka to pay upfront fee, potential future milestone payments; Halozyme eligible for mid-single-digit royalties on net sales of products using Hypercon.
  • Hypercon microparticle technology aims to reduce injection volume for a given dose, supporting more convenient administration.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oruka Therapeutics Inc. published the original content used to generate this news brief on May 06, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.